临床输血与检验2024，Vol.26Issue(2)：164-173,10.DOI:10.3969/j.issn.1671-2587.2024.02.003
ABO不同型血浆输注的风险认知与临床实践进展
Risks of ABO Non-identical Plasma:Cognitive and Clinical Practice
张雷英 1于洋1
作者信息
- 1. 解放军总医院第一医学中心输血医学科,北京 100853
- 折叠
摘要
Abstract
Plasma transfusion is clinically used to replenish clotting factors and correct coagulopathy,playing an important role in the treatment of massive hemorrhage.Universal plasma and low titer group O whole blood can improve the timeliness and accessibility of urgent transfusions in patients with major bleeding.The strategy of ABO non-identical plasma transfusion,in the form of active and passive transfusion,has been extensively adopted in clinical practice.Active transfusion mainly includes group AB and A plasma;passive transfusion,on the other hand,involves the transfusion of low titer group O whole blood and ABO non-identical platelets.However,hemolysis and circulating immune complex formation are recognized to be the risks associated with transfusion of ABO non-identical plasma.Together,the risk-benefit trade-off with transfusion of non-ABO identical plasma deserves more attention and further exploration.关键词
ABO不同型/ABO不相容/血浆/全血/血小板/风险Key words
ABO non-identical/ABO-Incompatible/Plasma/Whole blood/Platelet/Risk分类
医药卫生引用本文复制引用
张雷英,于洋..ABO不同型血浆输注的风险认知与临床实践进展[J].临床输血与检验,2024,26(2):164-173,10.
